Multicentric, Randomized Phase III Trial of Two Different Adjuvant Chemotherapy Regimens plus Three Versus Twelve Months of Trastuzumab in Patients with HER2-Positive Breast Cancer (Short-HER Trial; NCT00629278)Valentina Guarneri, PierFranco Conte, Antonio Frassoldati et al.|Clinical Breast Cancer|2008Cited by 57
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic SettingDaniele Generali, Gabriella Mariani, Filippo Montemurro et al.|The Oncologist|2017Cited by 11
Cystic tumors of the breast: a diagnostic and therapeutical problem.Giuseppe Moretto, Caroline A. Prezzi, Franco Bonetti et al.|Unknown|1997Cited by 0